Polystyrene Sulfonic Lanthanum

聚苯乙烯磺酸镧

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePolystyrene Sulfonic Lanthanum
Drug Alias NameLanthanum Polystyrene Sulphonate
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsHyperphosphatemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYuanda Life Science (Shandong) Co LtdLiaoning Great Kang Biological Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLiaoning Great Kang Biological Pharmaceutical Co LtdYuanda Life Science (Shandong) Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperphosphatemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A